E. Leibenluft et al., EFFECTS OF EXOGENOUS MELATONIN ADMINISTRATION AND WITHDRAWAL IN 5 PATIENTS WITH RAPID-CYCLING BIPOLAR DISORDER, The Journal of clinical psychiatry, 58(9), 1997, pp. 383-388
Background: The ready availability of exogenous melatonin means that i
ts use in patients with mood disorders is probably not uncommon. Nonet
heless, few controlled trials of exogenous melatonin in these patients
have been conducted. Method: Five patients with rapid-cycling DSM-III
-R bipolar disorder were treated with melatonin 10 mg q.d. at 10:00 p.
m. for 12 weeks. Melatonin was added to a stable regimen of medication
and administered in a double-blind, placebo-controlled fashion. Resul
ts: Melatonin administration had no positive effects. One patient deve
loped a free-running (unentrained) sleep-wake cycle after melatonin wi
thdrawal. In addition, in both this and a second patient, there is evi
dence that the administration of exogenous melatonin may have suppress
ed the secretion of endogenous melatonin. Conclusion: The administrati
on of melatonin had no significant effects on mood or sleep. However,
melatonin withdrawal delayed sleep onset time and may have had some mi
ld mood-elevating effects.